Republic of the Philippines
Office of the President

Dangerous Drugs Board

News Releases

President Duterte issues EO to establish, support rehab centers

Published on Monday, 17 October 2016

The Office of the President issued Executive Order No. 4 to create an inter-agency task force for the establishment and support of drug abuse treatment and rehabilitation centers throughout the Philippines. It is part of the continuous efforts of the government in the campaign against illegal drugs. The said EO will ensure that the growing numbers of drug dependents who have voluntarily surrendered to the authorities will be provided with appropriate treatment and rehabilitation services.

One of the functions of the Task Force is to establish the needed drug abuse treatment and rehabilitation centers and provide support for their operations, with authority to call for assistance of government agencies involve in the said implementation. They are also tasked to issue relevant guidelines for the effective implementation of the EO.

The task force is composed of the Secretary of the Department of the Interior and Local Government (DILG) as the Chairperson; Secretary of the Department of Health (DOH) and Chairman of the Dangerous Drugs Board (DDB) as the Vice Chairpersons; and the members are composed of Secretaries from the Department of Social Welfare and Development (DSWD) and the Department of Budget and Management (DBM), Director General of the Philippine Drug Enforcement Agency (PDEA) and a Representative from the Office of the President.

Executive Order No. 4 was issued last October 11, 2016 at the Malcañan Palace.

Download the Executive Order No. 4, click here.

Announcement: Increase in fee for issuance of Certification of Non-Controlled Products and Certificate of Exemption

Published on Friday, 09 September 2016

The Dangerous Drugs Board would like to advise our dear clients and stakeholders of the increase in the fee for issuance of Certification of non-controlled products and Certificate of Exemption for products containing controlled chemicals above the limit of concentration.

A fee of P300.00 shall now be charged per Certification of ten (10) item. Exempted from payment of fees are national government agencies and government controlled or owned corporations and foreign counterpart regulatory or enforcement agencies.

The fee is increased from P150.00 by virtue of Board Regulation No. 1, Series of 2014.

Public Hearing on inclusion of new substances in the list of dangerous drugs

Published on Friday, 26 August 2016

The Dangerous Drugs Board invites representatives of pharmaceutical companies, chemical industries, medical professionals, and interested parties to the Public Hearing on the proposed inclusion of Gamma Butyro-Lactone (GBL) in the list of dangerous drugs.

Inclusion of the following substances recently listed under different schedules of United Nations Conventions: Acetylfentanyl, MT-45, Para-Methoxymethamphetamine (PMMA), A-Pyrrolidinovalerophone (A-PVP), para-Methyl-4methylaminorex (4,4-DMAR), Methoxetamine (MXE), and Phenazepam, will also be discussed.

The Public Hearing will be held on 2 September 2016 (Friday), 1:30 PM, at the Dangerous Drugs Board Conference Room, 3rd Floor, DDB-PDEA Building, NIA Road, Barangay Pinyahan, Diliman, Quezon City.

Should there be concerned and interested parties that would like to submit position papers on the matter, please address it to Undersecretary Rommel L. Garcia, Chairman, Public Hearings Committee and send it (in soft and hard copies) not later than 30 August 2016.

Pursuant to Section 93, Article XI of Republic Act 9165 or the Comprehensive Dangerous Drugs Act of 2002, the Board has the power to classify, re-classify, add or delete substances in the list of dangerous drugs.

To ensure that proper regulatory mechanisms are installed for dangerous drugs and substances and legitimate use will not be compromised, public hearings are conducted with stakeholders.

President Duterte appoints new DDB Chair; Outgoing Sec. Rojas ends DDB stint on a high note

Published on Friday, 26 August 2016

President Rodrigo Duterte has named a new head of the Dangerous Drugs Board.

The new chairman of the DDB is its former Assistant Secretary and Deputy Executive Director for Operations, Benjamin P. Reyes.

With his years of experience on the anti-drug advocacy and his background on health, Secretary Reyes will lead the DDB as it continues to develop and implement a balanced and comprehensive strategy against drugs.

Meanwhile, outgoing Secretary Rojas has ended his stint at the DDB in high spirits as he was able to oversee accomplishment of a number of the Board’s target. Among these are the development of guidelines on handling surrendering drug personalities, partnership with the Public Attorney’s Office on processing of petitions for confinement to treatment and rehabilitation, and presentation of proposed amendments to RA 9165 in the Congress.

“I am thankful for the opportunity to serve and work with the people of the DDB,” he said during the general assembly of DDB employees on Friday morning where he also announced the appointment of the new Chairman.

Outgoing Secretary Rojas is set to focus on his family and private business but will continue to support the anti-drug advocacy. “I am looking on helping support treatment and rehabilitation of some drug dependents,” he said.
He also said that he is certain that Sec. Reyes will continue to improve the services of the DDB.  “Keep up the good work,” he further told employees.

The DDB Secretariat received the appointment papers of Sec. Reyes as Chairman of the DDB, vice Felipe L. Rojas, Jr., dated 24 August 2016.

Sec. Reyes will take his oath of office next week.

Public Attorneys can now process petitions for voluntary confinement to treatment and rehabilitation

Published on Tuesday, 23 August 2016

Drug dependents who would voluntarily submit themselves to treatment and rehabilitation can now seek the help of lawyers from the Pubic Attorney’s Office (PAO) to act as their counsel and represent them before courts.

This is after the signing of a Memorandum of Agreement between the Dangerous Drugs Board (DDB) and PAO on August 22.

As per the Comprehensive Dangerous Drugs Act of 9165 or RA 9165, a drug dependent or through a parent, spouse or guardian will have to apply to the DDB or its duly recognized representative for treatment and rehabilitation.

Upon application, the petition will be filed in court and based on results of drug dependency examination by an accredited physician, the court will order the confinement of the dependent in a treatment and rehabilitation facility.

With the agreement with PAO, drug dependents now can seek the help of PAO lawyers nationwide. Atty. Persida V. Rueda-Acosta, during the MOA signing, also stressed that this service is free of charge.

DDB Chairman Sec. Felipe L. Rojas Jr., regards this as a very important development especially with the influx of surrendering drug users seeking treatment and rehabilitation. “We are very grateful to PAO for granting our request and for supporting our advocacy to save drug dependents from the clutches of drugs and re-integrate them into the society as productive citizens,” he said.

The MOA between DDB and PAO is effective immediately and covers the national and all regional offices.

Citizen's Charter


idadin portal



world trends











Announcements and Advisory

New Processing Time for Certification and Exemption

Published on Tuesday, 07 July 2015

To all concerned clients and stakeholders:

The Legal Division of the Dangerous Drugs Board receives numerous requests for Certificate of No Controlled Chemicals and Certificate of Exemption. In a bid to efficiently process and proficiently evaluate all these requests, we will be implementing a schedule for the submission of applications and walk-in inquiries.

Starting on 20 July 2015 (Monday), submission of applicants and walk-in inquiries shall be accommodated by our personnel from 8:00 AM to 2:00 PM on regular office days. This will allow us to process applications thereafter.

We are hoping for your understanding and cooperation.

Legal Division
Dangerous Drugs Board

List of Hospitals Distributing Yellow Prescription Pad (2015)

Published on Thursday, 22 January 2015


To all Physicians, Dentists, Veterinarians, or Practitioners:

The Department of Health-Special Concerns Technical Cluster-Dangerous Drug Abuse Prevention and Treatment Program (SCTC-DDAPTP) announces the availability of Yellow Prescription Pads for sale at selected DOH distribution sites. (Please see complete list under Downloads section in the side bar portion of the DDB website).


Published on Tuesday, 20 January 2015



Effective February 4, 2015 (Wednesday), all applications and attached annexes for certificate of non-controlled chemicals and certificate of exemtion shall submitted in pdf format of said application and attached annexes to be placed in a CD or USB Flash Drive. The requirement aims to improve file management and reduce paper usage in the office.

Applications submitted after the said date without the soft copy requirement shall not be accepted.

Thank you for your cooperation.

Certification and Exemption Requests

Published on Monday, 04 August 2014

Please enclose a SELF - ADDRESSED STAMPED ENVELOPE if you wish to have your certification / exemption mailed to your company through registered mail only. Please ensure that you have placed the proper amount of stamps in a legal - size envelope in order to have the certification / exemption delivered through registerd mail.

Yellow Pad Advisory (05 April 2013)

Published on Friday, 05 April 2013


In the interest of public service, please be informed that due to unavailability of the DOH-Special Prescription Form (Yellow Pad), the use of Ordinary Personalized Prescription Form is HEREBY EXTENDED UNTIL SUCH TIME THE DOH SPECIAL PRESCRIPTION FORMS shall be readily available.

Furthermore, the same shall be in triplicate form, the ordinary copy of which shall be surrendered to the drugstore or pharmacy that dispense the dangerous drugs, the duplicate copy shall remain with the patient or purchaser-representative, and the third copy shall be retained by the prescribing physician.

This advisory shall take effect immediately.

(Sgd) Undersecretary JOSE MARLOWE S. PEDREGOSA
Executive Director
05 April 2013

Click here to download the advisory...

This Week
Last Week
This Month
Last Month
All days

Your IP:
Server Time: 2016-10-21 16:56:12